View More Recent Stories

Jul 29, 2024 04:01PM Verastem Oncology (VSTM) Receives FDA Orphan Drug Designation for Avutometinib and Defactinib for the Treatment of Pancreatic Cancer

Jul 29, 2024 07:15AM Verastem (VSTM) PT Lowered to $7 at Mizuho

Jul 24, 2024 07:02AM Verastem (VSTM) PT Lowered to $7 at B.Riley

Jul 23, 2024 04:07PM Verastem Oncology (VSTM) Announces Proposed Share Offering

Jul 8, 2024 11:18AM Verastem (VSTM) PT Lowered to $18 at Truist Securities

View More Recent Stories